Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
People with end stage renal disease have anemia mainly due to erythropoietin deficiency. Living donor renal transplantation corrects anemia by restoring endogenous erythropoietin production. Timing of recovery of anemia and its progress over time in living donor renal transplant recipients were not studied in Myanmar. This study found out improvement in anemia and its mode of recovery over six months in living donor renal transplant recipients.
A hospital-based longitudinal study was conducted at 1,000 bedded public hospital in Myanmar from December 2023 to July 2025. After getting informed consent, clinical examination, red cell indices (Hemoglobin, RBC count, Hematocrit HCT and RBC distribution width RDW) and serum creatinine were measured at ten time-points; pre-transplant period, Day 1, Day 7, Day 14, Month 1, Month 2, Month 3, Month 4, Month 5 and Month 6.
A total of 57 living donor renal transplant recipients were included; all recipients had normochromic normocytic anemia prior to transplant. Mean pre-transplant hemoglobin (Hb) was 10.64 ± 1.2 g/dL. And it fell to 8.83 ± 1.4 g/dL on Day 1. Then, it progressively increased to 12.59 ± 1.6 g/dL at Month 2, to 12.68 ± 1.5 g/dL at Month 3 and 13.39 ± 1.5 g/dL at Month 6. Both RBC count and HCT showed parallel recovery pattern. RDW peaked at 16.45% on Day 14 and stabilized at 13.74% by Month 6. At Month 6, anemia resolved in 93.0% (53/57). And, 7.0% (4/57) of them remained anemic; their mean hemoglobin was 10.1 g/dL. Two of them had SLE (systemic lupus erythematosus) and they had bone marrow involvement of SLE. The remaining two recipients had chronic rejection and their serum creatinine was 1.4 mg%. Hb improvements generally paralleled with creatinine declines.
All recipients had anemia in pre-transplant period. In most recipients, hemoglobin increased significantly by Month 2 and it became normal by Month 6. A clinically relevant inverse trend was observed between Hb and creatinine though statistical correlations was weak.
